Mujagić H, Mujagić Z
Clinical Oncology Services, Medical Faculty, University of Banja Luka, Bosna, Yugoslavia.
Oncology. 1991;48(3):202-9. doi: 10.1159/000226928.
We describe the development of an immunofluorescent method for the detection of resistance to agents which affect the integrity of the cellular microtubular network. Three pleiotropic resistant MCF-7 human breast carcinoma cell lines mixed with vaginal adenocarcinoma cells were selected in serially increasing drug concentrations, and demonstrated a 30-fold increase in resistance to colchicine. Transport studies indicated that there was no difference in drug accumulation between the sensitive and resistant lines. The colchicine-binding capacity of cell extracts from sensitive and resistant cells was similar (Kd for sensitive cells was 1.9 x 10(-6) M and for resistant cells 1.58 x 10(-6) M). There were, however, significant differences in cytoskeletal morphology between sensitive and resistant cells. Drug-sensitive cells were mostly large (about 70 microns 2) and flattened. Their cytoplasm was filled with a microtubular network in which, in most of the cases, single fibers could be differentiated. Cells usually had a microtubule-organizing center and paracortical bundles of microtubules. In contrast, drug-resistant cells were mostly rounded and grew in clumps. In only 40% of these cells could single microtubular fibers be differentiated. Resistant cells lacked a microtubule-organizing center and had no clear paracortical bundles of microtubules. The tubulin-binding agents tested caused a sequence of morphological changes in sensitive cells. These changes included precipitation of tubulin and disappearance of cytoskeletal structure. Changes occurred initially within 3 h of incubation, but were expressed in all cells after 6 h. If, after 3 h of drug exposure, cells were subcultured in drug-free media, the cytoskeletal structure reformed within 10 h. Maximal recovery of cytoskeletal structure occurred 22 h after drug removal and was sustained up to 36 h. In contrast to changes observed in sensitive cells, drug exposure did not induce changes in the morphology of cytoskeleton in resistant cells. Cells from all three resistant lines reverted to sensitivity after 7 months of culture in drug-free media. This was first detected by immunofluorescence and then confirmed by cloning assay. Since the cytoskeletal disintegration of sensitive cells is readily detectable within a few hours of in vitro drug treatment, immunofluorescent imaging may have its clinical application in predicting the sensitivity/resistance to microtubule-binding agents.
我们描述了一种免疫荧光方法的开发,用于检测对影响细胞微管网络完整性的药物的抗性。在不断增加的药物浓度中连续选择三种多效抗性MCF-7人乳腺癌细胞系与阴道腺癌细胞混合,结果显示对秋水仙碱的抗性增加了30倍。转运研究表明,敏感细胞系和抗性细胞系在药物积累方面没有差异。敏感细胞和抗性细胞提取物的秋水仙碱结合能力相似(敏感细胞的解离常数Kd为1.9×10⁻⁶M,抗性细胞为1.58×10⁻⁶M)。然而,敏感细胞和抗性细胞在细胞骨架形态上存在显著差异。药物敏感细胞大多较大(约70微米²)且扁平。它们的细胞质充满微管网络,在大多数情况下,可以区分出单根纤维。细胞通常有一个微管组织中心和皮质旁微管束。相比之下,耐药细胞大多呈圆形并成簇生长。在这些细胞中,只有40%能够区分出单根微管纤维。抗性细胞缺乏微管组织中心,也没有明显的皮质旁微管束。所测试的微管蛋白结合剂在敏感细胞中引起了一系列形态变化。这些变化包括微管蛋白沉淀和细胞骨架结构消失。变化最初在孵育3小时内出现,但6小时后在所有细胞中都有表现。如果在药物暴露3小时后,将细胞接种到无药物培养基中,细胞骨架结构会在10小时内重新形成。细胞骨架结构在药物去除后22小时达到最大恢复,并持续到36小时。与敏感细胞中观察到的变化相反,药物暴露并未诱导抗性细胞的细胞骨架形态发生变化。在无药物培养基中培养7个月后,所有三个抗性细胞系的细胞都恢复了敏感性。这首先通过免疫荧光检测到,然后通过克隆试验得到证实。由于敏感细胞的细胞骨架解体在体外药物处理后几小时内即可轻易检测到,免疫荧光成像在预测对微管结合剂的敏感性/抗性方面可能具有临床应用价值。